vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and OLAPLEX HOLDINGS, INC. (OLPX). Click either name above to swap in a different company.
OLAPLEX HOLDINGS, INC. is the larger business by last-quarter revenue ($105.1M vs $85.1M, roughly 1.2× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -12.5%, a 35.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 4.3%). OLAPLEX HOLDINGS, INC. produced more free cash flow last quarter ($32.6M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 3.1%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
FDMT vs OLPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $105.1M |
| Net Profit | $19.4M | $-13.1M |
| Gross Margin | — | 68.0% |
| Operating Margin | 17.3% | -4.3% |
| Net Margin | 22.8% | -12.5% |
| Revenue YoY | 8508900.0% | 4.3% |
| Net Profit YoY | 139.1% | -48.9% |
| EPS (diluted) | $0.43 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $105.1M | ||
| Q3 25 | $90.0K | $114.6M | ||
| Q2 25 | $15.0K | $106.3M | ||
| Q1 25 | $14.0K | $97.0M | ||
| Q4 24 | $1.0K | $100.7M | ||
| Q3 24 | $3.0K | $119.1M | ||
| Q2 24 | $5.0K | $103.9M | ||
| Q1 24 | $28.0K | $98.9M |
| Q4 25 | $19.4M | $-13.1M | ||
| Q3 25 | $-56.9M | $11.1M | ||
| Q2 25 | $-54.7M | $-7.7M | ||
| Q1 25 | $-48.0M | $465.0K | ||
| Q4 24 | — | $-8.8M | ||
| Q3 24 | $-43.8M | $14.8M | ||
| Q2 24 | $-35.0M | $5.8M | ||
| Q1 24 | $-32.4M | $7.7M |
| Q4 25 | — | 68.0% | ||
| Q3 25 | — | 69.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 69.5% | ||
| Q4 24 | — | 66.3% | ||
| Q3 24 | — | 68.6% | ||
| Q2 24 | — | 69.7% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 17.3% | -4.3% | ||
| Q3 25 | -67983.3% | 3.7% | ||
| Q2 25 | -396373.3% | -1.1% | ||
| Q1 25 | -383007.1% | 8.7% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -1704400.0% | 23.5% | ||
| Q2 24 | -849120.0% | 15.7% | ||
| Q1 24 | -136200.0% | 19.8% |
| Q4 25 | 22.8% | -12.5% | ||
| Q3 25 | -63195.6% | 9.7% | ||
| Q2 25 | -364386.7% | -7.3% | ||
| Q1 25 | -342657.1% | 0.5% | ||
| Q4 24 | — | -8.7% | ||
| Q3 24 | -1461433.3% | 12.4% | ||
| Q2 24 | -699060.0% | 5.6% | ||
| Q1 24 | -115717.9% | 7.8% |
| Q4 25 | $0.43 | $-0.02 | ||
| Q3 25 | $-1.01 | $0.02 | ||
| Q2 25 | $-0.98 | $-0.01 | ||
| Q1 25 | $-0.86 | $0.00 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.79 | $0.02 | ||
| Q2 24 | $-0.63 | $0.01 | ||
| Q1 24 | $-0.66 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $318.7M |
| Total DebtLower is stronger | — | $352.3M |
| Stockholders' EquityBook value | $505.7M | $879.4M |
| Total Assets | $566.7M | $1.5B |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $318.7M | ||
| Q3 25 | $305.1M | $286.4M | ||
| Q2 25 | $293.2M | $289.3M | ||
| Q1 25 | $321.4M | $580.9M | ||
| Q4 24 | $424.9M | $586.0M | ||
| Q3 24 | $501.9M | $538.8M | ||
| Q2 24 | $541.9M | $507.9M | ||
| Q1 24 | $525.9M | $507.5M |
| Q4 25 | — | $352.3M | ||
| Q3 25 | — | $352.1M | ||
| Q2 25 | — | $351.9M | ||
| Q1 25 | — | $649.1M | ||
| Q4 24 | — | $650.5M | ||
| Q3 24 | — | $651.8M | ||
| Q2 24 | — | $653.1M | ||
| Q1 24 | — | $654.4M |
| Q4 25 | $505.7M | $879.4M | ||
| Q3 25 | $369.0M | $888.7M | ||
| Q2 25 | $420.9M | $874.2M | ||
| Q1 25 | $469.7M | $878.3M | ||
| Q4 24 | $510.6M | $874.4M | ||
| Q3 24 | $552.9M | $879.7M | ||
| Q2 24 | $588.3M | $863.3M | ||
| Q1 24 | $600.6M | $855.7M |
| Q4 25 | $566.7M | $1.5B | ||
| Q3 25 | $424.0M | $1.5B | ||
| Q2 25 | $473.6M | $1.5B | ||
| Q1 25 | $515.7M | $1.8B | ||
| Q4 24 | $560.4M | $1.8B | ||
| Q3 24 | $604.0M | $1.8B | ||
| Q2 24 | $620.1M | $1.8B | ||
| Q1 24 | $629.9M | $1.8B |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $32.7M |
| Free Cash FlowOCF − Capex | $28.5M | $32.6M |
| FCF MarginFCF / Revenue | 33.5% | 31.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $32.7M | ||
| Q3 25 | $-46.5M | $8.0M | ||
| Q2 25 | $-43.4M | $20.9M | ||
| Q1 25 | $-47.8M | $-2.9M | ||
| Q4 24 | $-134.6M | $49.7M | ||
| Q3 24 | $-29.4M | $33.5M | ||
| Q2 24 | $-30.2M | $16.2M | ||
| Q1 24 | $-29.1M | $43.7M |
| Q4 25 | $28.5M | $32.6M | ||
| Q3 25 | $-46.6M | $7.9M | ||
| Q2 25 | $-43.4M | $20.8M | ||
| Q1 25 | $-48.4M | $-3.0M | ||
| Q4 24 | $-138.4M | $49.2M | ||
| Q3 24 | $-31.2M | $33.3M | ||
| Q2 24 | $-30.6M | $16.1M | ||
| Q1 24 | $-29.8M | $43.3M |
| Q4 25 | 33.5% | 31.0% | ||
| Q3 25 | -51765.6% | 6.9% | ||
| Q2 25 | -289620.0% | 19.6% | ||
| Q1 25 | -345635.7% | -3.1% | ||
| Q4 24 | -13837100.0% | 48.9% | ||
| Q3 24 | -1038966.7% | 28.0% | ||
| Q2 24 | -611840.0% | 15.5% | ||
| Q1 24 | -106421.4% | 43.7% |
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 101.1% | 0.1% | ||
| Q2 25 | 440.0% | 0.1% | ||
| Q1 25 | 4507.1% | 0.0% | ||
| Q4 24 | 378600.0% | 0.4% | ||
| Q3 24 | 59266.7% | 0.1% | ||
| Q2 24 | 6980.0% | 0.1% | ||
| Q1 24 | 2535.7% | 0.5% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.81× | ||
| Q1 24 | — | 5.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
